Onset of significant GH dependence of serum IGF-I and IGF-binding protein 3 concentrations in early life

Pediatric Research

Volumn 50, Issue 6, 2001, Pages 737-742

  Low, L C K ^a   Tam, S Y M ^a   Kwan, E Y W ^a   Tsang, A M C ^a   Karlberg, J ^a,b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD SAMPLING; BODY HEIGHT; BODY MASS; CHILD; CHILD GROWTH; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HORMONE ACTION; HORMONE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; INFANT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; VELOCITY;

EID: 0035199299     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/00006450-200112000-00018     Document Type: Article

References (44)

1. The endocrine regulation of fetal growth in late gestation: The role of insulin-like growth factors
2. Congenital idiopathic growth hormone deficiency associated with prenatal and early postnatal growth failure: The International Board of the Kabi Pharmacia International Growth Study
3. Insulin, insulin-like growth factor I (IGF-I), IGF-binding protein 1, growth hormone and feeding in the newborn
4. Role of insulin-like growth factors in embryonic and postnatal growth
5. Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene
6. Tissue and plasma somatomedin-C/insulin-like growth factor I concentrations in the human fetus during the first half of gestation
7. Fetal insulin-like growth factor (IGF)-I and IGF-II are regulated differently by glucose or insulin in the sheep fetus
8. Growth hormone response to feeding in term and preterm neonates
9. Functional hypersomatotropism in small for gestational age (SGA) newborn infants
10. Insulin-like growth factor (IGF)-I and IGF-binding protein 3 during the first year in term and preterm infants
11. The induction of hepatic somatotrophic receptors after birth in sheep is dependent on parturition-associated mechanisms
12. The ontogeny of serum GH binding protein in man: A possible indicator of hepatic GH receptor development
13. Plasma levels of insulin-like growth factor binding protein-I, and growth hormone binding protein activity from birth to the third month of life
14. On the modelling of human growth
15. Estimation of somatomedin C levels in normals and patients with pituitary disease by radioimmunoassay
16. Insulin-like growth factors
17. Free insulin-like growth factor I serum levels in 1430 healthy children and adults and its diagnostic value in patients suspected of growth hormone deficiency
18. Early variations of plasma somatomedin activity in the newborn
19. Insulin-like growth factor I (IGF-I) in healthy children, adolescents and adults as determined by a radioimmunoassay specific for synthetic 53-70 peptide region
20. Circulating insulin like growth factor I levels in newborn premature and full-term infants followed longitudinally
21. Plasma somatomedin-C during the first year of life
22. Insulin-like growth factor I, insulin-like growth factor binding proteins, and growth hormone binding protein in Spanish premature and full-term newborn
23. High ratio of free to total insulin-like growth factor I in early infancy
24. Growth factors and intrauterine growth retardation II. Serum growth hormone, insulin-like growth factor (IGF) I, and IGF-binding protein 3 levels in children with intrauterine growth retardation compared with normal control subjects: Prospective study from birth to two years of age
25. Serum free insulin-like growth factor I (IGF-I), total IGF-I and IGF-binding protein-3 concentrations in normal children and children with growth hormone deficiency
26. Long-term consequences of early linear growth retardation (stunting) in Swedish children
27. The improvement in growth, socioeconomic and health status in Hong Kong Chinese infants: 1967 to 1994
28. The effects of pancreatectomy on the plasma concentrations of insulin-like growth factors-1 and -2 in the sheep fetus
29. Evidence for pituitary regulation of somatic growth, insulin-like growth factors 1 and 2 and their binding proteins in the fetal rat
30. Growth factors and intrauterine growth retardation I. Serum growth hormone insulin-like growth factor (IGF)-I, IGF-II, and IGF binding protein 3 levels in normally grown and growth retarded human fetuses during the second half of gestation
31. Nutritional regulation of IGF-I and IGF binding proteins
32. Spontaneous growth hormone release in term infants: Changes during the first four days of life
33. Growth hormone secretion in children determined by time series analysis
34. Evidence for generation of the growth hormone binding protein through proteolysis of the growth hormone membrane receptor
35. Does serum growth hormone (GH) binding protein reflect human GH receptor function?
36. Placental lactogen and growth hormone receptors in human fetal tissues: Relationship to fetal plasma human placental lactogen concentrations and fetal growth
37. Serum growth hormone binding actively in healthy neonates, children and young adults: Correlation with age height and weight
38. Binding protein for human growth hormone; effect of age and weight
39. Normative data for insulin-like growth factors (IGFs), IGF-binding proteins, and growth hormone-binding protein in a healthy Spanish pediatric population: Age- and sex-related changes
40. Growth hormone-binding protein activity, is inversely related to 24-hour growth hormone release in normal boys
41. The worldwide magnitude of protein energy malnutrition: An overview from the WHO Global Database on Child Growth
42. Evaluation of growth hormone binding proteins in human plasma using HPLC-gel filtration
43. Insulin-like growth factor I comparisons in healthy twin children
44. Circadian variation in serum free ultrafiltrable insulin-like growth factor I concentrations in healthy children